http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010120683-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_063db76bd92ed2957cd476ee010969a4
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-572
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001189
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
filingDate 2009-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18f789be3da977c3540c9894bb393f15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4565bb22fbaef8f9ef8d134485c4a3c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1f911451ef9e478ce20ff9b61594556
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d7d1609142964885e8c50181972ac40
publicationDate 2010-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-2010120683-A1
titleOfInvention Prame derived peptides and immunogenic compositions comprising these
abstract The invention relates to a peptide having a length of no more than 100 amino acids and comprising at least 19 contiguous amino acids from the amino acid sequence of the human PRAME protein, wherein the peptide comprises at least one HLA class II epitope and at least one HLA class I epitope from the amino acid sequence of the human PRAME protein and to its use as such or in a composition as a medicament for the treatment and/or prevention of cancer.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10188712-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11628209-B2
priorityDate 2007-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6339149-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011269949-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5830753-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7820786-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6297050-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005221440-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6022692-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396546
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395397
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129341575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129105713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129741655
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3084050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3325
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135794158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123822
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12954996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226422066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530

Total number of triples: 50.